Read all of CMAC’s consultation responses, statements and opinion statements
- CMAC and MHP Group host a series of webinars about Access to Medicines
- Statement about Department of Health & Social Care (DHSC) Consultation: changes to NICE regulations: cost-effectiveness threshold
- CMAC statement – UK/US trade deal
- Statement on Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) accelerated review
- Response to NICE’s consultation on the criteria for highly specialised technologies
- Response to the Commercial Framework consulation – part 1
- Joint statement on the Commercial Framework consultation
- Response to consulation about the inclusion of technology appraisal recommendations in NICE guidelines
- Response to consulation about NICE’s integrated topic prioritisation and strategic principles
- Joint open letter about the renewal of Voluntary scheme for branded medicines pricing and access negotations
- A joint statement on the voluntary scheme for branded medicines pricing and access (VPAS)
